Frontiers in Oncology | Cancer Genetics

Original Research

Published on 29 May 2017

Involvement of Chromatin Remodeling Genes and the Rho GTPases RhoB and CDC42 in Ovarian Clear Cell Carcinoma

in Cancer Genetics

Nicolai Skovbjerg Arildsen
Jenny-Maria Jönsson
Katarina Bartuma
Anna Ebbesson
Sofia Westbom-Fremer
Anna Måsbäck
Susanne Malander
Mef Nilbert
Ingrid A. Hedenfalk

Frontiers in Oncology

doi 10.3389/fonc.2017.00109

5,654 views
21 citations

Original Research

Published on 15 Feb 2017

Inhibition of DNA and Histone Methylation by 5-Aza-2′-Deoxycytidine (Decitabine) and 3-Deazaneplanocin-A on Antineoplastic Action and Gene Expression in Myeloid Leukemic Cells

in Cancer Genetics

Richard L. Momparler
Sylvie Côté
Louise F. Momparler
Youssef Idaghdour

Frontiers in Oncology

doi 10.3389/fonc.2017.00019

17,158 views
25 citations

Original Research

Published on 08 Jun 2016

Polymorphisms of Insulin-Like Growth Factor 1 Pathway Genes and Breast Cancer Risk

in Cancer Genetics

Joy Shi
Kristan J. Aronson
Anne Grundy
Lindsay C. Kobayashi
Igor Burstyn
Johanna M. Schuetz
Caroline A. Lohrisch
Sandip K. SenGupta
Agnes S. Lai
Angela Brooks-Wilson

Frontiers in Oncology

doi 10.3389/fonc.2016.00136

4,241 views
10 citations

Editorial

Published on 03 Jun 2016

Editorial: Hereditary Cancer Risk Assessment: New Perspectives and Challenges for the Next-Gen Sequencing Era

in Cancer Genetics

Israel Gomy

Frontiers in Oncology

doi 10.3389/fonc.2016.00133

2,419 views

Original Research

Published on 13 Apr 2016

Differences of Variable Number Tandem Repeats in XRCC5 Promoter Are Associated with Increased or Decreased Risk of Breast Cancer in BRCA Gene Mutation Carriers

in Cancer Genetics

Jian Cui
Jiangtao Luo
Yeong C. Kim
Carrie Snyder
Dina Becirovic
Bradley Downs
Henry Lynch
San Ming Wang

Frontiers in Oncology

doi 10.3389/fonc.2016.00092

4,172 views
12 citations

Correction

Published on 02 Dec 2015

Corrigendum: Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management

in Cancer Genetics

Thomas Paul Slavin
Mariana Niell-Swiller
Ilana Solomon
Bita Nehoray
Christina Rybak
Kathleen R. Blazer
Jeffrey N. Weitzel

Frontiers in Oncology

doi 10.3389/fonc.2015.00271

2,360 views
14 citations

Original Research

Published on 29 Oct 2015

Putative Breast Cancer Driver Mutations in TBX3 Cause Impaired Transcriptional Repression

in Cancer Genetics

Kathrin Fischer
Gert O. Pflugfelder

Frontiers in Oncology

doi 10.3389/fonc.2015.00244

7,280 views
22 citations

Review

Published on 26 Oct 2015

Preventing Damage Limitation: Targeting DNA-PKcs and DNA Double-Strand Break Repair Pathways for Ovarian Cancer Therapy

in Cancer Genetics

Daniela A. Dungl
Elaina N. Maginn
Euan A. Stronach

Frontiers in Oncology

doi 10.3389/fonc.2015.00240

7,386 views
28 citations

Opinion

Published on 21 Oct 2015

Ovarian Cancer Molecular Stratification and Tumor Heterogeneity: A Necessity and a Challenge

in Cancer Genetics

Stefan Symeonides
Charlie Gourley

Frontiers in Oncology

doi 10.3389/fonc.2015.00229

5,583 views
19 citations

Original Research

Published on 12 Oct 2015

Association between CLN3 (Neuronal Ceroid Lipofuscinosis, CLN3 Type) Gene Expression and Clinical Characteristics of Breast Cancer Patients

in Cancer Genetics

Joelle Makoukji
Mohamad Raad
Katia Genadry
Sally El-Sitt
Nadine J. Makhoul
Ehab Saad Aldin
Eden Nohra
Mark Jabbour
Ajanthah Sangaralingam
Claude Chelala

Frontiers in Oncology

doi 10.3389/fonc.2015.00215

7,165 views
15 citations

Original Research

Published on 29 Sep 2015

Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management

in Cancer Genetics

Thomas Paul Slavin
Mariana Niell-Swiller
Ilana Solomon
Bita Nehoray
Christina Rybak
Kathleen R. Blazer
Jeffrey N. Weitzel

Frontiers in Oncology

doi 10.3389/fonc.2015.00208

14,565 views
100 citations

Review

Published on 30 Jun 2015

Harnessing Pandemonium: The Clinical Implications of Tumor Heterogeneity in Ovarian Cancer

in Cancer Genetics

Sarah P. Blagden

Frontiers in Oncology

doi 10.3389/fonc.2015.00149

8,177 views
57 citations

Opinion

Published on 23 Mar 2015

Hereditary Cancer Risk Assessment: Challenges for the Next-Gen Sequencing Era

in Cancer Genetics

Hugo Pinheiro
Patrícia Oliveira
Carla Oliveira

Frontiers in Oncology

doi 10.3389/fonc.2015.00062

4,353 views
2 citations

Original Research

Published on 26 Nov 2014

Differential Gene Expression Landscape of Co-Existing Cervical Pre-Cancer Lesions Using RNA-seq

in Cancer Genetics

Kathryn E. Royse
Degui Zhi
Michael G. Conner
Buffie Clodfelder-Miller
Vinodh Srinivasasainagendra
Laura Kelly Vaughan
Christine F. Skibola
David K. Crossman
Shawn Levy
Sadeep Shrestha

Frontiers in Oncology

doi 10.3389/fonc.2014.00339

8,830 views
27 citations

Review

Published on 23 Sep 2014

The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models

in Cancer Genetics

Amancio Carnero
Jesus M. Paramio

Frontiers in Oncology

doi 10.3389/fonc.2014.00252

53,156 views
194 citations

Perspective

Published on 21 Aug 2014

Asymmetric Cell Division and Template DNA Co-Segregation in Cancer Stem Cells

in Cancer Genetics

Sharon R. Pine
Wenyu Liu

Frontiers in Oncology

doi 10.3389/fonc.2014.00226

9,655 views
17 citations

Navigation group

Articles

Involvement of Chromatin Remodeling Genes and the Rho GTPases RhoB and CDC42 in Ovarian Clear Cell Carcinoma

Inhibition of DNA and Histone Methylation by 5-Aza-2′-Deoxycytidine (Decitabine) and 3-Deazaneplanocin-A on Antineoplastic Action and Gene Expression in Myeloid Leukemic Cells

Polymorphisms of Insulin-Like Growth Factor 1 Pathway Genes and Breast Cancer Risk

Editorial: Hereditary Cancer Risk Assessment: New Perspectives and Challenges for the Next-Gen Sequencing Era

Differences of Variable Number Tandem Repeats in XRCC5 Promoter Are Associated with Increased or Decreased Risk of Breast Cancer in BRCA Gene Mutation Carriers

Corrigendum: Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management

Putative Breast Cancer Driver Mutations in TBX3 Cause Impaired Transcriptional Repression

Preventing Damage Limitation: Targeting DNA-PKcs and DNA Double-Strand Break Repair Pathways for Ovarian Cancer Therapy

Ovarian Cancer Molecular Stratification and Tumor Heterogeneity: A Necessity and a Challenge

Association between CLN3 (Neuronal Ceroid Lipofuscinosis, CLN3 Type) Gene Expression and Clinical Characteristics of Breast Cancer Patients

Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management

Harnessing Pandemonium: The Clinical Implications of Tumor Heterogeneity in Ovarian Cancer

Hereditary Cancer Risk Assessment: Challenges for the Next-Gen Sequencing Era

Differential Gene Expression Landscape of Co-Existing Cervical Pre-Cancer Lesions Using RNA-seq

The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models

Asymmetric Cell Division and Template DNA Co-Segregation in Cancer Stem Cells